Jan 19, 2021
InVixa announces licensing deal with University of California, Davis for the commercialization of novel inhaled statins for the treatment of COVID-19

Davis, California, USA – InVixa Inc (‘InVixa’),a biopharmaceutical start-up developing inhaled statins to treat COVID-19, announced today an exclusive......

Jan 11, 2021
11-15 Jan - Invixa will be attending the Biotech Showcase

Please email Simon Bennett to meet with us.